MAGEA3 and melanoma: Adult melanomas expressed NY-ESO-1 (48.3%, n = 14) and MAGE-A3 (75.9%, n = 22) much more frequently than either young adult or pediatric melanomas (Fig. 2c, Supplementary Table 4).